In a Facebook post, deputy government spokesperson Traisulee Traisoranakul said the vaccine, developed by Dr Kiat Ruxrungtham from Chulalongkorn University, will be tested on 100 volunteers this month.
The clinical trial also aims to work out the right dosage for immunization. Once the trial is successfully completed, the first lot of vaccines will be produced in the US, before Thailand’s BioNet-Asia begins mass production in September.
Published : June 01, 2021
By : The Nation